Baird Financial Group, Inc. Atri Cure, Inc. Transaction History

Baird Financial Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$35.1 - $66.01 $1,825 - $3,432	52 Added 0.9%	5,823 $238,000
Q1 2022 May 13, 2022	BUY	$57.43 - $71.39 $62,828 - $78,100	1,094 Added 23.39%	5,771 $379,000
Q4 2021 Feb 09, 2022	BUY	$63.4 - $87.14 $4,438 - $6,099	70 Added 1.52%	4,677 $325,000
Q3 2021 Nov 12, 2021	BUY	$69.28 - $84.46 $319,172 - $389,107	4,607 New	4,607 $320,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.43B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.